| Line Item | 2025-12-27 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $665.5M | +24.7% | +65.5% |
| Gross Profit | $240.1M | +32.3% | +141.1% |
| R&D Expense | $80.1M | -1.6% | +8.0% |
| SG&A Expense | $96.1M | +12.9% | +26.0% |
| Operating Income | $64.3M | +859.7% | +224.6% |
| Income Tax | $18.3M | +1730.0% | -1.6% |
| Net Income | $78.2M | +1761.9% | +228.4% |
| EPS (Basic) | $1.10 | +1733.3% | +225.0% |
| EPS (Diluted) | $0.89 | +1680.0% | +201.1% |
| Line Item | 2025-12-27 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $657.7M | -14.9% | +37.1% |
| Short-term Investments | $497.6M | +42.6% | +19.3% |
| Inventory | $570.4M | +7.3% | +41.8% |
| Current Assets | $2.28B | +9.5% | +38.3% |
| Total Assets | $4.81B | +4.2% | +21.2% |
| Current Liabilities | $3.77B |
| Line Item | 2025-12-27 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $184.6M | +218.8% | — |
| Capital Expenditures | $159.8M | +109.7% | — |
| Investing Cash Flow | -$299.2M | -341.3% | — |
| Financing Cash Flow | $251.6M | -4.0% | — |
| Free Cash Flow | $24.8M | +235.5% | — |
| +986.1% |
| Long-term Debt | $47.1M | -97.8% | -98.2% |
| Total Liabilities | $3.96B | +3.3% | +28.0% |
| Stockholders' Equity | $846.6M | +8.4% | -2.9% |